Method for separating and extracting PBMC (peripheral blood mononuclear cells)

By optimizing peripheral blood pretreatment, Ficoll density gradient centrifugation, and washing steps, combined with adjusting erythrocyte hematocrit with physiological saline and controlling the gas path system, the problems of low efficiency and high cost in existing PBMC separation methods have been solved, achieving efficient and low-cost separation of large-capacity PBMCs.

CN121320244APending Publication Date: 2026-01-13SINO-BIOCAN BIOLOGY TECH (SHANGHAI) LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511712435.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-11-20
Publication Date
2026-01-13

AI Technical Summary

Technical Problem

Existing PBMC separation methods suffer from problems such as low separation efficiency, high cost, poor automation, and high dependence on blood quality and operational skills, especially when processing large sample volumes.

Method used

Peripheral blood pretreatment, Ficoll density gradient centrifugation and washing steps, combined with physiological saline to adjust erythrocyte hematocrit, density gradient separation and washing solution optimization, and control of centrifugal force and centrifugation strategy, combined with gas path system to control liquid inflow and outflow, were used to achieve efficient separation of PBMCs.

Benefits of technology

It significantly improves the separation efficiency and activity of PBMCs, reduces the use of reagents and consumables, shortens processing time, and is suitable for efficient separation of large-volume samples.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121320244A_ABST
    Figure CN121320244A_ABST
Patent Text Reader

Abstract

The invention discloses a method for separating and extracting PBMC (peripheral blood mononuclear cells), which comprises the following steps: on the premise of retaining PBMC in a sample, carrying out volume reduction treatment on a sample solution, namely, carrying out volume reduction on the sample solution to discharge a certain amount of plasma and red blood cells, and then carrying out ficoll solution centrifugation, so as to carry out one-time PBMC separation operation on a large-volume sample; the process flow time of PBMC separation and extraction is greatly shortened, the cell yield is high, the activity is high, and an effective cell acquisition way is provided for clinical and basic cytology research so as to facilitate subsequent immune cell experiments; according to the separation and extraction method, less separation liquid, washing liquid (replacement liquid) and disposable consumables are used, so that the time, consumables and reagent cost are saved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of cell extraction technology, and in particular to a method for separating and extracting PBMCs. Background Technology

[0002] Peripheral blood mononuclear cells (PBMCs) are cells with a single nucleus in peripheral blood. They are a part of the white blood cell line and mainly include monocytes, lymphocytes (B cells and T cells), phagocytes, dendritic cells, and NK cells. These cells are important cells in the body's immune response.

[0003] Current methods for isolating PBMCs mainly include adhesion assays, immunomagnetic bead separation, flow cytometry, and the classic Ficoll-Hypaque density gradient centrifugation. Adhesion assays utilize the adhesion of monocytes to plastic or glass surfaces to separate them from other blood cells. The disadvantages of this method are low cell viability and purity, and susceptibility to variations in cell source and culture conditions. Immunomagnetic bead separation utilizes specific antigens on the surface of monocytes and antibodies bound to magnetic beads, using a magnetic field to separate them from other blood cells. The disadvantages of this method are high cost and the need for specialized equipment and operating techniques. Flow cytometry utilizes fluorescent markers on the surface of monocytes and the detection and sorting capabilities of a flow cytometer to separate them from other blood cells. However, the disadvantages of this method are expensive equipment and the need for specialized personnel and software. Ficoll-Hypaque density gradient centrifugation utilizes the density difference between monocytes and other blood cells in Ficoll solution to separate them through centrifugation. This method is currently the most commonly used PBMC isolation method, but its disadvantages are susceptibility to variations in blood quality and operator skill. Regardless of the separation method mentioned above, if the sample size is too large, it will either be impossible to process, or the automation level will be poor, the processing time will be too long, and a lot of reagents will be used, resulting in low separation efficiency and a significant increase in cost.

[0004] Therefore, it is essential to develop a new method for separating and extracting PBMCs, which will further improve the activity, recovery rate and separation efficiency of PBMCs and has broad application prospects and great field value. Summary of the Invention

[0005] This invention overcomes the shortcomings of the prior art and provides a method for separating and extracting PBMCs.

[0006] This invention provides a method for separating and extracting PBMCs, which includes the following steps: Peripheral blood pretreatment: After centrifugation and separation of the sample solution, most of the plasma layer is removed. During centrifugation, plasma, the white membrane layer, and red blood cells near the white membrane layer are collected and used as the first residual sample solution. A certain amount of physiological saline is added to the uncollected residual sample solution, mixed, and centrifuged. The supernatant, white blood cells, and red blood cells near the white blood cell layer are collected and used as the second residual sample solution. Density gradient separation: The first and second remaining sample solutions are mixed as the target sample solution, and the target sample solution is subjected to Ficoll density gradient centrifugation to collect the Ficoll layer and the leukocyte layer; Washing: Add washing solution to the Ficoll layer and the leukocyte layer, centrifuge, wash and replace, and separate to obtain the product.

[0007] Further, the volume of the sample solution can be 100mL~350mL (e.g., 100mL, 110mL, 120mL, 130mL, 140mL, 145mL, 150mL, 155mL, 160mL, 165mL, 170mL, 175mL, 180mL, 185mL, 190mL, 195mL, 200mL, 210mL, 220mL, 230mL, 240mL, 250mL, 260mL, 270mL, 280mL, 290mL, 300mL, 310mL, 315mL, 320mL, 325mL, 340mL, 345mL, 350mL), preferably 150~320mL.

[0008] Furthermore, the purpose of peripheral blood pretreatment is to retain as many PBMCs as possible in the original sample, remove excess red blood cells and plasma, reduce the sample volume during the next step of Ficoll density gradient centrifugation, and adjust the hematocrit (HCT) of the reduced-volume sample to between 35% and 45% by adding an appropriate amount of physiological saline, thereby saving process time and Ficoll usage, improving efficiency, reducing costs, and minimizing PBMC viability loss.

[0009] Furthermore, the reason for collecting red blood cells near the white membrane layer in the peripheral blood pretreatment step is that, due to the sedimentation velocity and position, some white blood cells will inevitably mix with red blood cells. Therefore, it is necessary to collect a portion of red blood cells to reduce the loss of white blood cells.

[0010] Furthermore, the purpose of collecting the second residual sample solution in the peripheral blood pretreatment step is to collect as many residual white blood cells as possible from the remaining sample solution (mostly residual red blood cells) excluding the first residual sample solution. The purpose of adding saline is, on the one hand, to adjust the HCT of the reduced sample to about 35%-45%, and on the other hand, to improve the recovery rate of white blood cells in the second residual sample solution.

[0011] Furthermore, to reduce the loss of PBMCs during peripheral blood pretreatment, when centrifuging and separating the sample solution, a steady centrifugation strategy is adopted when the sample solution is a normal sample; an accelerated / decelerated centrifugation strategy is adopted when the sample solution is an anemic sample; and a strategy of removing plasma, adding physiological saline, mixing, and centrifuging is adopted when the sample solution is a hyperlipidemic sample.

[0012] In one embodiment of the present invention, when the sample solution is a normal sample, a stable centrifugation strategy is adopted: the centrifuge is started, and when the centrifugal force reaches 800g, this centrifugal force is stably maintained for a certain period of time to achieve a better stratification effect.

[0013] In one embodiment of the present invention, when the sample solution is an anemia sample, an acceleration and deceleration centrifugation strategy is adopted: start the centrifuge, after the centrifuge reaches 300g, maintain this centrifugal force stably for a certain period of time, then slowly increase it to 800g, and then slowly decrease it to 300g to achieve a good centrifugation stratification effect.

[0014] In one embodiment of the present invention, when the sample solution is a high blood lipid sample, a strategy is adopted to remove the plasma, add physiological saline, mix and centrifuge: start centrifugation, after the centrifuge reaches 600g, maintain this centrifugal force stably for a certain period of time, after forming a stable plasma layer, drain a portion of the plasma, draw an appropriate amount of washing liquid from the washing bag, mix and then centrifuge stably to form a stable layer.

[0015] Furthermore, the method also includes a step of collecting products, which are either initial products or final products; The step of collecting the initial product includes: emptying the residual white blood cells in the pipeline and mixing them with the product separated in the aforementioned washing step to obtain the initial product; The steps for collecting the final product include: emptying the residual white blood cells in the separation cup, and emptying the residual white blood cells in the tubing, and mixing the residual white blood cells obtained from both steps with the initial product to obtain the final product.

[0016] Furthermore, the method for clearing residual white blood cells from the pipeline includes the following steps: a filter is installed on the outlet pipeline of the separation cup, the filter is connected to a pressure sensor, and the pressure sensor is also connected to an air pump. Compressed air is applied to the air pump to clear residual white blood cells from the pipeline; the pressure sensor is used to detect the pressure inside the separation cup.

[0017] Furthermore, the separating cup is a piston-type separating cup, and the separating cup and the diaphragm pump are connected through a certain air passage to form an air passage system. The air passage system controls the liquid entering and exiting the separating cup by applying positive or negative pressure to the piston of the separating cup to drive the piston of the separating cup to move up or down, thereby achieving uniform liquid entry and exit.

[0018] Furthermore, the washing includes a first washing and a second washing, wherein the washing includes mixing the replacement solution one with the Ficoll layer and the leukocyte layer, centrifuging, separating the layers, and discharging the upper mixture after separation to obtain the leukocyte layer, wherein the upper mixture is Ficoll, replacement solution one and plasma.

[0019] Furthermore, after the washing step, there is also a step of mixing the product evenly.

[0020] Furthermore, the process of clearing the residual white blood cells from the separation cup includes the following steps: washing the separation cup several times with replacement solution II, and mixing the drained solution with the initial product.

[0021] Furthermore, the replacement solution is selected from one or more of the following: physiological saline, PBS buffer, magnesium sulfate solution, calcium chloride solution, glucose solution, sodium bicarbonate solution, and potassium chloride solution; Preferably, the replacement solution two is a cell cryopreservation solution.

[0022] Furthermore, before performing density gradient separation on the target sample solution, the tubing is flushed with physiological saline.

[0023] Furthermore, the sample liquid inlet and outlet methods described in this invention include fixed-volume inlet, fixed-volume outlet, complete discharge of the separation device, and complete entry of the liquid bag (fuzzy inlet).

[0024] In one embodiment of the present invention, the fixed-volume liquid injection includes the following steps: 1) Open the corresponding pipeline valve and adjust the diaphragm pump pressure to positive pressure +25 kPa. A: If the separation equipment is in the centrifugation process, it is necessary to increase the negative pressure generated by the centrifuge tank during centrifugation. If the centrifugal force is 500g, it is necessary to increase by 37kPa. The pressure of the diaphragm pump needs to be adjusted to positive pressure to +62kPa. B: If the separation equipment is in a forward and reverse mixing state, do not increase the pressure, and still adjust the diaphragm pump pressure to positive pressure to +25kPa; C: If the separation equipment is in unidirectional acceleration and deceleration mixing, it is necessary to add 1 / 3 of the negative pressure generated at the maximum centrifugal force. For a mixing centrifugal force of 500g, an additional centrifugal force of 12.3 is required. The diaphragm pump pressure needs to be adjusted to positive pressure to +37.3kPa. 2) After adjusting the diaphragm pump pressure for 2 seconds, start judging the flow rate of the sample liquid. If the flow rate is 0, increase the pressure by +8 kPa to make the liquid start to flow. Continue to judge the flow rate. If the flow rate is still 0, continue to increase the pressure. Before the liquid flows, each pressurization should be increased by 8 kPa until the liquid flows. 3) After the liquid starts flowing, check the flow rate. If the flow rate is greater than the preset value, such as 30 g / min, adjust the diaphragm pump pressure drop by 3 kPa. If the flow rate is too low, such as less than 10 g / min, adjust the diaphragm pump pressure increase by 3 kPa. For trace amounts, the pressure can be adjusted multiple times to maintain an average flow rate of around 20 g / min, such as 15 g / min, 16 g / min, 17 g / min, 18 g / min, 19 g / min, 20 g / min, 21 g / min, 22 g / min, 23 g / min, 24 g / min, or 25 g / min. 4) When the total weight of the liquid reaches the set value, first close the corresponding valve in the pipeline, and then adjust the pressure of the diaphragm pump to 0.

[0025] In this invention, PBMC refers to peripheral blood mononuclear cells, which are cells in peripheral blood that have a single nucleus, including lymphocytes and monocytes, preferably leukocytes.

[0026] The method described in this invention significantly shortens the process time for PBMC separation and extraction, resulting in high cell yield and high activity. It provides an effective cell acquisition route for clinical and basic cell research for subsequent immune cell experiments. The separation and extraction method uses less separation solution, washing solution (replacement solution), and disposable consumables, allowing for a single PBMC separation operation on large-volume samples, saving time, consumables, and reagent costs. Attached Figure Description

[0027] Figure 1 The diagram shows the state of white blood cells and blood cells in the separation device before the second centrifugation operation.

[0028] Figure 2 The diagram shows the state of each component in the sample in the separation device after Ficoll density gradient centrifugation.

[0029] Figure 3 The diagram shows the state of the white blood cells and the mixture in the separation device after the first wash.

[0030] Figure 4 The diagram shown is a layout diagram of consumables.

[0031] Figure 5 The image shown is a front view of the separation device.

[0032] Figure 6 The diagram shows the process flow chart for rapid separation of peripheral blood PBMCs. Detailed Implementation

[0033] In order to better understand the technical content of the present invention, the following embodiments are provided in detail. The purpose of these embodiments is only to better understand the content of the present invention and not to limit the scope of protection of the present invention.

[0034] Figure label: 1-Sample bag, 2-Replacement II, 3-Ficoll bag, 4-Waste liquid bag, 5-Replacement I, 6-Product bag, 7-Pipeline valve, 8-Diaphragm pump.

[0035] Example 1 A method for separating and extracting PBMCs ( Figure 6 The diagram shown is a flowchart of a rapid separation process for peripheral blood PBMCs, which includes the following steps: (a) Peripheral blood pretreatment 1) Fuzzy injection No total sample volume needs to be set; simply add the amount of sample according to the user's bag size. It can process 150-320 ml of sample. Injection ends when the air detector detects continuous gas, or when the piston reaches its limit after the container is full. During sample injection, a tubing detector is used to monitor the sample status (or manually input) to determine the sample type. Different sample types employ different centrifugation strategies in the peripheral blood pretreatment centrifugation step. See the front view of the separation equipment. Figure 5 .

[0036] 2) Centrifugation Start the centrifuge and centrifuge for a specified time according to the user-set centrifugal force. During this time, the peripheral blood will separate into three layers from the center outwards: plasma, a white membrane layer (platelets + white blood cells), and red blood cells. Different strategies are used for centrifugation timing for different samples.

[0037] Normal sample - stable centrifugation strategy: Start the centrifuge, and when the centrifugal force reaches 800g, maintain this centrifugal force stably for a certain period of time to achieve a better stratification effect; Anemia Samples - Acceleration / Deceleration Centrifugation Strategy: Start the centrifuge and, once it reaches 300g, maintain this centrifugal force stably for a certain period of time. Then, slowly increase the speed to 800g, and then slowly decrease it back to 300g to achieve good centrifugation stratification.

[0038] High blood lipid samples - remove plasma and then mix and centrifuge: Start the centrifuge, and after the centrifuge reaches 600g, maintain this centrifugal force stably for a certain period of time to form a stable plasma layer. After that, drain a portion of the plasma, draw an appropriate amount of washing solution from the washing bag, mix well, and then centrifuge stably again to form a stable stratification.

[0039] 3) Drain the upper layer of blood plasma into the waste bag. After the centrifugation timer is completed (without stopping the centrifuge), the upper layer of plasma is discharged into the waste bag -4. When the component detector in the tubing detects the white film layer, a certain volume is then returned to the separation cup to complete the process.

[0040] 4) Drain the reduced-volume blood into sample bag-1 (this step mainly collects the white blood cell layer and the upper red blood cell layer). A. After draining the plasma, drain a certain amount of the remaining cell fluid into sample bag-1 according to the settings (due to the short pretreatment time, the separation of the white membrane layer and the red blood cell layer is not obvious except for the plasma layer, so the remaining cell fluid is a mixture of platelets, white blood cells, and red blood cells). If the amount of plasma drained is less than 30% of the total sample volume, then add 20g to the set amount. This step is for special samples where the plasma separation effect is not good during centrifugation, and there is still a lot of plasma in the aforementioned remaining cell fluid. Increasing the collection volume improves the recovery rate of PBMCs. B. After discharging the set volume into sample bag-1, stop the centrifuge. Mix the cells a certain number of times by accelerating and decelerating in one direction within the centrifuge, then restart the centrifuge and continue centrifuging for a certain period of time. Then, discharge a certain amount of the remaining cell solution into sample bag-1. The purpose of this second centrifugation is to recover as many PBMCs from the blood as possible. Figure 1 As shown, because some white blood cells were initially close to the centrifuge wall before centrifugation, they could not be moved to the center of the centrifuge during centrifugation. The mixing process allows most of the white blood cells to aggregate to the center of the centrifuge via a second centrifugation and be collected in sample bag-1. At this point, the remaining cells in the centrifuge are primarily red blood cells.

[0041] 5) Empty the centrifuge tank Stop the centrifuge, drain the remaining red blood cells from the centrifuge tank into waste bag 4, and empty the tubing.

[0042] (ii) Density gradient separation 1) Enter Ficoll Add Ficoll, and adjust the amount added to Ficoll bag-3 according to user settings or system defaults. Then start the centrifuge and reach a certain speed.

[0043] 2) Input of pretreated samples Transfer the reduced-volume sample from sample bag-1 into the centrifuge tank while centrifuging, using a method of initial high speed followed by slow speed and then high speed again. After transferring the sample, add an appropriate amount of physiological saline to the centrifuge tank to clean the tubing and prevent residual red blood cells from depositing or adhering to the tube walls.

[0044] 3) Centrifugation timing: Red blood cells and white blood cells are separated by centrifugation over a certain period of time, utilizing the gradient formed with Ficoll. For example... Figure 2 As shown, because red blood cells have a higher density than Ficoll, they pass through the Ficoll layer and reach the outermost layer of the centrifuge tank during the centrifugation process. PBMCs, on the other hand, have a lower density than Ficoll and are blocked by the Ficoll layer, thus achieving the separation of red blood cells and PBMCs.

[0045] 4) Collect initial products After the centrifugation timer expires, transfer the initial product to product bag -6 and collect the leukocytes and Ficoll layer separated during centrifugation. The process ends when the probe reaches the point where PBMCs have been collected.

[0046] 5) Empty the centrifuge tube Stop centrifugation, drain the remaining liquid from the centrifuge tank into the waste bag, and wash away any remaining cells using a method similar to replacing liquid 1-5 while mixing it with the liquid, then draining it into the waste bag-4. Repeat this washing process three times to ensure all remaining cells in the centrifuge tank and tubing are washed into the waste bag-4. Empty the tubing as well.

[0047] (iii) Washing 1) Initial product re-extraction The initial product in product bag-6 is pumped back into the centrifuge tank.

[0048] 2) First wash A: Add a certain amount of Displacement 1-5 liquid to the product bag, then pump it all into a centrifuge tank and mix thoroughly to achieve the effect of cleaning the product. Displacement 1-5 can be physiological saline or other washing solutions used by the user.

[0049] B: Add the replacement solution 1-5 according to the user-set initial washing amount, minus the bag washing amount of 30g, and mix while adding the liquid into the centrifuge tank.

[0050] C: During centrifugation, the centrifugal force is set according to the user-defined initial wash centrifugal force. Separate white blood cells and the mixture (Ficoll, replacement solution 1, and a small amount of plasma).

[0051] D: Drain the waste liquid. After draining the upper layer of waste liquid, the remaining amount in the bucket is the amount of white blood cells to be collected (e.g., the amount retained in the bucket). Figure 3 (As shown).

[0052] 3) Second wash: A: Add the replacement solution 1-5 according to the user-set secondary washing dosage, mixing it thoroughly as you add the solution into the centrifuge tank.

[0053] B: When centrifuging, the centrifugal force is set according to the centrifugal force for the second wash, and the separation effect is the same as that of the first wash.

[0054] C: Drain the waste liquid. After draining the upper layer of waste liquid, the remaining liquid in the tank is the amount retained in the tank.

[0055] (iv) Receiving products 1) Receiving products A: After washing, stop the centrifuge and mix the product in the centrifuge tank by accelerating and decelerating in one direction at least 3 times.

[0056] B: After mixing, drain the cells from the bucket into the product bag and empty any remaining material from the tubing into product bag-6.

[0057] 2) Wash the centrifuge drum A: Add the cryopreservation solution from Replacement 2-2 to the centrifuge tank according to the user-set amount (default 10g), mixing while adding the solution, and then mixing at least 3 times after adding the solution.

[0058] B: While mixing, drain the washing liquid into product bag-6, then empty the pipeline residue into product bag-6. At this point, the final product is obtained.

[0059] Example 2 In terms of total processing time, the process of this invention saves a significant amount of time compared to the traditional PBMC separation and extraction process.

[0060] The process of this invention involves multiple emptying of pipeline residues and management of inlet and outlet liquids.

[0061] (a) Clear the pipeline of residual material To clear residual particles from the pipeline, a filter is installed on the outlet pipeline of the separation cup. The filter is connected to a pressure sensor, which is also connected to an air pump. Compressed air is applied to the air pump to clear residual blemishes from the pipeline, thus achieving a rapid pipeline clearing effect and saving approximately 10 minutes of process time. See [link / reference]. Figure 4 .

[0062] Traditional pipeline cleaning methods: From the pipeline pressure sensor, the centrifuge tank diaphragm pump pressure is adjusted to negative pressure, so that the pressure inside the centrifuge tank is less than -15kPa. The DPM valve is opened, waits for a few seconds, and then the DPM valve is closed to achieve the effect of air intake. The centrifuge tank diaphragm pump pressure is adjusted to positive pressure, and the corresponding pipeline valve is opened to allow air inside the centrifuge tank to be discharged outwards, thus removing pipeline residue to the corresponding bag.

[0063] The pump pipeline emptying method described in this invention is as follows: 1) Open the corresponding pipeline valve-7. The pressure of the diaphragm pump-8 is directly adjusted to positive pressure and pressurized for 3 seconds. A control piston is set on the diaphragm pump-7 to achieve uniform liquid inflow and outflow, thus achieving flow rate control. After centrifugation time, the liquid has already achieved stratification. If the flow rate is uneven or too high during the liquid inflow and outflow process, it will disrupt the stratification and fail to achieve the desired separation effect. Therefore, the diaphragm pump control piston solves this problem.

[0064] (ii) Management of inlet and outlet liquids For sample solutions, the inlet and outlet methods are divided into fixed volume inlet, fixed volume outlet, centrifuge bucket full discharge, and liquid bag full entry (fuzzy inlet).

[0065] The following describes the diaphragm pump control method using a fixed inlet. Liquid injection method: 1) Open the corresponding pipeline valve -7 and adjust the pressure of the diaphragm pump -8 to +25 kPa. A: If the centrifuge is in the centrifugation process, the negative pressure generated by the centrifuge tank needs to be increased. If the centrifugal force is 500g, it needs to be increased by 37kPa. The pressure of the diaphragm pump -8 needs to be adjusted to +62kPa.

[0066] B: If the centrifuge is in a forward and reverse mixing state, do not increase the pressure, but still adjust the diaphragm pump -8 pressure to +25kPa.

[0067] C: If the centrifuge is in unidirectional acceleration and deceleration mixing, it is necessary to add 1 / 3 of the negative pressure generated at the maximum centrifugal force. For a mixing centrifugal force of 500g, an additional centrifugal force of 12.3 is required. The pressure of the diaphragm pump -8 needs to be adjusted to +37.3kPa.

[0068] 2) After the pressure is turned on for 2 seconds, start judging the flow rate. If the flow rate is 0, increase the pressure by +8 kPa to make the liquid start to flow. Continue to judge the flow rate. If the flow rate is still 0, continue to increase the pressure. Before the liquid flows, each pressurization is increased by 8 kPa until the liquid flows.

[0069] 3) After the liquid starts flowing, check the flow rate. If the flow rate is greater than the preset value, such as 30 g / min, adjust the diaphragm pump pressure drop by 3 kPa. If the flow rate is too low, such as less than 10 g / min, adjust the diaphragm pump pressure up by 3 kPa. For small amounts, the pressure can be adjusted multiple times to maintain an average flow rate of around 20 g / min.

[0070] 4) When the total weight of the liquid reaches the set value, first close the corresponding valve in the pipeline, then adjust the pressure of the diaphragm pump -8 to 0 to complete this drainage.

Claims

1. A method for separating and extracting PBMCs, comprising the following steps: Peripheral blood pretreatment: After centrifugation and separation of the sample solution, most of the plasma layer is removed. During centrifugation, plasma, the white membrane layer, and red blood cells near the white membrane layer are collected and used as the first residual sample solution. A certain amount of physiological saline is added to the uncollected residual sample solution, mixed, and centrifuged. The supernatant, white blood cells, and red blood cells near the white blood cell layer are collected and used as the second residual sample solution. Density gradient separation: The first and second remaining sample solutions are mixed as the target sample solution, and the target sample solution is subjected to Ficoll density gradient centrifugation to collect the Ficoll layer and the leukocyte layer; Washing: Add washing solution to the Ficoll layer and the leukocyte layer, centrifuge, wash and replace, and separate to obtain the product.

2. The method as described in claim 1, characterized in that, When centrifuging and separating the sample solution, a steady centrifugation strategy is used when the sample solution is a normal sample; an accelerated and decelerated centrifugation strategy is used when the sample solution is an anemic sample; and a strategy of removing plasma, adding physiological saline, mixing, and centrifuging is used when the sample solution is a hyperlipidemic sample.

3. The method as described in claim 1, characterized in that, The method also includes a step of collecting products, which are either primary or final products. The step of collecting the initial product includes: emptying the residual white blood cells in the pipeline and mixing them with the product obtained by separation as described in claim 1 to obtain the initial product; The steps for collecting the final product include: emptying the residual white blood cells in the separation cup, and emptying the residual white blood cells in the tubing, and mixing the residual white blood cells obtained from both steps with the initial product to obtain the final product.

4. The method as described in claim 3, characterized in that, The method for clearing residual white blood cells from the pipeline includes the following steps: a filter is installed on the outlet pipeline of the separation cup, the filter is connected to a pressure sensor, and the pressure sensor is also connected to an air pump. Compressed air is applied to the air pump to clear the residual white blood cells from the pipeline; the pressure sensor is used to detect the pressure inside the separation cup.

5. The method as described in claim 3 or 4, characterized in that, The separator cup is a piston-type separator cup. The separator cup and the diaphragm pump are connected by a certain air passage to form an air passage system. The air passage system controls the liquid to enter and exit the separator cup by applying positive or negative pressure to the piston of the separator cup to drive the piston of the separator cup to move up or down, so as to achieve uniform liquid entry and exit.

6. The method as described in claim 1, characterized in that, The washing process includes a first wash and a second wash. The washing process includes mixing replacement solution one with the Ficoll layer and the leukocyte layer, centrifuging, separating the layers, and discharging the upper mixture after separation to obtain the leukocyte layer. The upper mixture consists of Ficoll, replacement solution one, and plasma.

7. The method as described in claim 1 or 6, characterized in that, Following the washing step, there is also a step of mixing the product evenly.

8. The method as described in claim 3, characterized in that, The process of emptying the separation cup of residual white blood cells includes the following steps: washing the separation cup several times with replacement solution II, and mixing the rinse solution with the initial product.

9. The method as described in claim 6, characterized in that, The replacement solution is selected from one or more of the following: physiological saline, PBS buffer, magnesium sulfate solution, calcium chloride solution, glucose solution, sodium bicarbonate solution, and potassium chloride solution; Preferably, the replacement solution two is a cell cryopreservation solution.

10. The method as described in claim 1, characterized in that, Before performing density gradient separation on the target sample solution, the tubing is flushed with physiological saline.